Ignite Creation Date:
2025-12-24 @ 11:24 PM
Ignite Modification Date:
2025-12-25 @ 9:10 PM
Study NCT ID:
NCT03425656
Status:
COMPLETED
Last Update Posted:
2024-06-28
First Post:
2017-11-21
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Comparing Efficacy and Safety of AryoGen Pharmed Biosimilar Trastuzumab (AryoTrust) Versus Herceptin® in Breast Cancer
Sponsor:
AryoGen Pharmed Co.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-07-09
Start Date Type:
ACTUAL
Primary Completion Date:
2018-03-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-08-05
Completion Date Type:
ACTUAL
First Submit Date:
2017-11-21
First Submit QC Date:
None
Study First Post Date:
2018-02-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-03-12
Results First Submit QC Date:
None
Results First Post Date:
2024-06-28
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-01-16
Last Update Post Date:
2024-06-28
Last Update Post Date Type:
ACTUAL